Steven C Quay - Net Worth and Insider Trading
Steven C Quay Net Worth
The estimated net worth of Steven C Quay is at least $39,151 dollars as of 2024-11-08. Steven C Quay is the President & CEO, 10% Owner of Atossa Therapeutics Inc and owns about 26,816 shares of Atossa Therapeutics Inc (ATOS) stock worth over $39,151. Details can be seen in Steven C Quay's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Steven C Quay has not made any transactions after 2016-03-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Steven C Quay
Steven C Quay Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Steven C Quay owns 2 companies in total, including Atossa Therapeutics Inc (ATOS) , and Adhera Therapeutics Inc (ATRX) .
Click here to see the complete history of Steven C Quay’s form 4 insider trades.
Insider Ownership Summary of Steven C Quay
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATOS | Atossa Therapeutics Inc | 2016-03-09 | director & 10 percent owner & CEO |
| ATRX | Adhera Therapeutics Inc | 2003-09-11 | President & CEO and Chairman |
Steven C Quay Latest Holdings Summary
Steven C Quay currently owns a total of 1 stock. Steven C Quay owns 26,816 shares of Atossa Therapeutics Inc (ATOS) as of March 9, 2016, with a value of $39,151.
Latest Holdings of Steven C Quay
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATOS | Atossa Therapeutics Inc | 2016-03-09 | 26,816 | 1.46 | 39,151 |
Holding Weightings of Steven C Quay
Steven C Quay Form 4 Trading Tracker
According to the SEC Form 4 filings, Steven C Quay has made a total of 0 transactions in Atossa Therapeutics Inc (ATOS) over the past 5 years. The most-recent trade in Atossa Therapeutics Inc is the acquisition of 83 shares on March 9, 2016, which cost Steven C Quay around $5,550.
Insider Trading History of Steven C Quay
- 1
Steven C Quay Trading Performance
GuruFocus tracks the stock performance after each of Steven C Quay's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steven C Quay is -5.45%. GuruFocus also compares Steven C Quay's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steven C Quay within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Steven C Quay's insider trading performs compared to the benchmark.
Performance of Steven C Quay
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 41.06 | | | | | |
| Relative Return to S&P 500(%) | 37.12 | | | | | |
Steven C Quay Ownership Network
Ownership Network List of Steven C Quay
Ownership Network Relation of Steven C Quay
Steven C Quay Owned Company Details
What does Atossa Therapeutics Inc do?
Who are the key executives at Atossa Therapeutics Inc?
Steven C Quay is the director & 10 percent owner & CEO of Atossa Therapeutics Inc. Other key executives at Atossa Therapeutics Inc include SVP & Finance and Accounting Heather Rees , CFO & General Counsel Kyle Guse , and director & 10 percent owner & Chief Scientific Officer Shu-chih Chen .
Atossa Therapeutics Inc (ATOS) Insider Trades Summary
Over the past 18 months, Steven C Quay made no insider transaction in Atossa Therapeutics Inc (ATOS). Other recent insider transactions involving Atossa Therapeutics Inc (ATOS) include a net sale of 0 shares made by Gregory L Weaver , and a net purchase of 25,000 shares made by Jonathan Finn .
In summary, during the past 3 months, insiders sold 0 shares of Atossa Therapeutics Inc (ATOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 50,000 shares of Atossa Therapeutics Inc (ATOS) were sold and 75,000 shares were bought by its insiders, resulting in a net purchase of 25,000 shares.
Atossa Therapeutics Inc (ATOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Atossa Therapeutics Inc Insider Transactions
Steven C Quay Mailing Address
Above is the net worth, insider trading, and ownership report for Steven C Quay. You might contact Steven C Quay via mailing address: 22026 20th Avenue S E, Suite 102, Bothell Wa 98021.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
